153 related articles for article (PubMed ID: 2846094)
1. Therapy of patients with human T-cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2.
Waldmann TA; Goldman CK; Bongiovanni KF; Sharrow SO; Davey MP; Cease KB; Greenberg SJ; Longo DL
Blood; 1988 Nov; 72(5):1805-16. PubMed ID: 2846094
[TBL] [Abstract][Full Text] [Related]
2. The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia.
Waldmann TA; White JD; Goldman CK; Top L; Grant A; Bamford R; Roessler E; Horak ID; Zaknoen S; Kasten-Sportes C
Blood; 1993 Sep; 82(6):1701-12. PubMed ID: 8400227
[TBL] [Abstract][Full Text] [Related]
3. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
4. Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma.
Waldmann TA
Important Adv Oncol; 1994; ():131-41. PubMed ID: 8206486
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac.
Waldmann TA; White JD; Carrasquillo JA; Reynolds JC; Paik CH; Gansow OA; Brechbiel MW; Jaffe ES; Fleisher TA; Goldman CK; Top LE; Bamford R; Zaknoen E; Roessler E; Kasten-Sportes C; England R; Litou H; Johnson JA; Jackson-White T; Manns A; Hanchard B; Junghans RP; Nelson DL
Blood; 1995 Dec; 86(11):4063-75. PubMed ID: 7492762
[TBL] [Abstract][Full Text] [Related]
6. Lymphokine receptors: a target for immunotherapy of lymphomas.
Waldmann TA
Ann Oncol; 1994; 5 Suppl 1():13-7. PubMed ID: 8172810
[TBL] [Abstract][Full Text] [Related]
7. 1992 Stohlman Memorial Lecture: targeting the IL-2 receptor.
Waldmann TA
Leukemia; 1993 Aug; 7 Suppl 2():S151-6. PubMed ID: 8361223
[TBL] [Abstract][Full Text] [Related]
8. Novel interleukin-2 dependent T-cell line derived from adult T-cell leukemia not associated with human T-cell leukemia virus type I.
Kagami Y; Tobinai K; Kinoshita T; Nagai H; Hotta T; Seto M; Ueda R; Saito H
Jpn J Cancer Res; 1993 Apr; 84(4):371-8. PubMed ID: 8390425
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
[TBL] [Abstract][Full Text] [Related]
11. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression.
Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J
J Mol Cell Immunol; 1985; 2(1):17-26. PubMed ID: 2978223
[TBL] [Abstract][Full Text] [Related]
12. Adult T cell leukemia: a potential target for ricin A chain immunotoxins.
Krönke M; Depper JM; Leonard WJ; Vitetta ES; Waldmann TA; Greene WC
Blood; 1985 Jun; 65(6):1416-21. PubMed ID: 2986744
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 2 receptor (Tac antigen) expression in HTLV-I-associated adult T-cell leukemia.
Waldmann TA; Longo DL; Leonard WJ; Depper JM; Thompson CB; Krönke M; Goldman CK; Sharrow S; Bongiovanni K; Greene WC
Cancer Res; 1985 Sep; 45(9 Suppl):4559s-4562s. PubMed ID: 2990687
[TBL] [Abstract][Full Text] [Related]
14. Comparison of anti-Tac and anti-transferrin receptor-conjugated liposomes for specific drug delivery to adult T-cell leukemia.
Hege KM; Daleke DL; Waldmann TA; Matthay KK
Blood; 1989 Nov; 74(6):2043-52. PubMed ID: 2679914
[TBL] [Abstract][Full Text] [Related]
15. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.
Waldmann TA; Greene WC; Sarin PS; Saxinger C; Blayney DW; Blattner WA; Goldman CK; Bongiovanni K; Sharrow S; Depper JM
J Clin Invest; 1984 Jun; 73(6):1711-8. PubMed ID: 6327770
[TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of interleukin-2 receptor (Tac antigen) in adult T-cell leukemia.
Uchiyama T; Wano Y; Tsudo M; Umadome H; Hori T; Tamori S; Uchino H; Yodoi J; Maeda M; Kobayashi N
Princess Takamatsu Symp; 1984; 15():253-8. PubMed ID: 6100643
[TBL] [Abstract][Full Text] [Related]
17. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.
Junghans RP; Waldmann TA; Landolfi NF; Avdalovic NM; Schneider WP; Queen C
Cancer Res; 1990 Mar; 50(5):1495-502. PubMed ID: 2406013
[TBL] [Abstract][Full Text] [Related]
18. The interleukin-2 receptor on malignant cells: a target for diagnosis and therapy.
Waldmann TA
Cell Immunol; 1986 Apr; 99(1):53-60. PubMed ID: 3019574
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric analysis of expression of interleukin-2 receptor beta chain (p70-75) on various leukemic cells.
Hoshino S; Oshimi K; Tsudo M; Miyasaka M; Teramura M; Masuda M; Motoji T; Mizoguchi H
Blood; 1990 Aug; 76(4):767-74. PubMed ID: 2383656
[TBL] [Abstract][Full Text] [Related]
20. The promiscuous IL-2/IL-15 receptor: a target for immunotherapy of HTLV-I-associated disorders.
Waldmann TA
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S179-85. PubMed ID: 8797721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
